GENERIC NAME: ribavirin
BRAND NAME: Rebetol, Copegus, Ribasphere, RibaPak, Moderiba
DRUG CLASS AND MECHANISM: Ribavirin is an antiviral drug. It is used in combination with interferon for the treatment of chronic hepatitis C. Although the exact mechanism of its action is unknown, it is thought to interfere with the production and/or action of viral DNA and RNA which are critical to the survival and multiplication of the virus. Ribavirin was approved by the FDA in December 1998.
SIDE EFFECTS: The most common side effect seen with the combination of ribavirin and interferon is a flu-like syndrome consisting of:
Other possible side effects that may occur during therapy with ribavirin and interferon are:
- difficulty breathing,
- itching, and
- alterations in taste perception.
Quick GuideHepatitis C Pictures Slideshow: Transmission, Symptoms and Treatment
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.